Koreckij T - Search Results

1

Inhibition of CCL2 signaling in combination with docetaxel treatment has profound inhibitory effects on prostate cancer growth in bone.

Kirk PS, Koreckij T, Nguyen HM, Brown LG, Snyder LA, Vessella RL, Corey E. Kirk PS, et al. Among authors: koreckij t. Int J Mol Sci. 2013 May 21;14(5):10483-96. doi: 10.3390/ijms140510483. Int J Mol Sci. 2013. PMID: 23698775 Free PMC article.

2

Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis.

Koreckij T, Nguyen H, Brown LG, Yu EY, Vessella RL, Corey E. Koreckij T, et al. Br J Cancer. 2009 Jul 21;101(2):263-8. doi: 10.1038/sj.bjc.6605178. Br J Cancer. 2009. PMID: 19603032 Free PMC article.

3

HE3235 inhibits growth of castration-resistant prostate cancer.

Koreckij TD, Trauger RJ, Montgomery RB, Pitts TE, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E. Koreckij TD, et al. Neoplasia. 2009 Nov;11(11):1216-25. doi: 10.1593/neo.09960. Neoplasia. 2009. PMID: 19881957 Free PMC article.

4

Low dose, alternating electric current inhibits growth of prostate cancer.

Koreckij TD, Hill C, Azure L, Nguyen H, Kunz LL, Azure A, Corey E, Lange P, Vessella RL. Koreckij TD, et al. Prostate. 2010 Apr 1;70(5):529-39. doi: 10.1002/pros.21087. Prostate. 2010. PMID: 19938042

5

Inhibition of angiopoietin-2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viability.

Morrissey C, Dowell A, Koreckij TD, Nguyen H, Lakely B, Fanslow WC, True LD, Corey E, Vessella RL. Morrissey C, et al. Prostate. 2010 Dec 1;70(16):1799-808. doi: 10.1002/pros.21216. Prostate. 2010. PMID: 20583134 Free PMC article.

6

Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway.

Morgan TM, Koreckij TD, Corey E. Morgan TM, et al. Curr Cancer Drug Targets. 2009 Mar;9(2):237-49. doi: 10.2174/156800909787580999. Curr Cancer Drug Targets. 2009. PMID: 19275762 Free PMC article. Review.

7

Molecular assays for the detection of prostate tumor derived nucleic acids in peripheral blood.

Jost M, Day JR, Slaughter R, Koreckij TD, Gonzales D, Kinnunen M, Groskopf J, Rittenhouse HG, Vessella RL, Reynolds MA. Jost M, et al. Mol Cancer. 2010 Jul 2;9:174. doi: 10.1186/1476-4598-9-174. Mol Cancer. 2010. PMID: 20598135 Free PMC article.

8

Ten-year Risk of Recall of Novel Spine Devices.

Ansley B, Koreckij T, Jin A, Bouloussa H, Cheng AL, Dubin J. Ansley B, et al. Among authors: koreckij t. Spine (Phila Pa 1976). 2024 Jan 26. doi: 10.1097/BRS.0000000000004939. Online ahead of print. Spine (Phila Pa 1976). 2024. PMID: 38273730

9

Prospective, randomized, multicenter study of intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: 24-Month treatment arm results.

Koreckij T, Kreiner S, Khalil JG, Smuck M, Markman J, Garfin S; INTRACEPT Trial Investigators. Koreckij T, et al. N Am Spine Soc J. 2021 Oct 26;8:100089. doi: 10.1016/j.xnsj.2021.100089. eCollection 2021 Dec. N Am Spine Soc J. 2021. PMID: 35141653 Free PMC article.

10

Prospective, randomized, multicenter study of intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: 12-month results.

Smuck M, Khalil J, Barrette K, Hirsch JA, Kreiner S, Koreckij T, Garfin S, Mekhail N; INTRACEPT Trial Investigators. Smuck M, et al. Among authors: koreckij t. Reg Anesth Pain Med. 2021 Aug;46(8):683-693. doi: 10.1136/rapm-2020-102259. Epub 2021 May 24. Reg Anesth Pain Med. 2021. PMID: 34031220 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page